Olfr1099 Activators represent a diverse array of chemical compounds that enhance the functional activity of Olfr1099 through several biochemical pathways, primarily focusing on the modulation of G-protein-coupled receptor (GPCR) signaling. Forskolin, by activating adenylate cyclase, increases intracellular cAMP levels, which in turn potentiates the GPCR pathways integral to Olfr1099's function. Similarly, 3-Isobutyl-1-methylxanthine and Sildenafil, both phosphodiesterase inhibitors, prevent cAMP breakdown, thereby sustaining enhanced signaling through the GPCR pathway. The specific binding of certain odorant molecules, such as aldehydes, directly activates Olfr1099, leading to olfactory signal transduction. Zinc ions can modulate the conformation and interaction of Olfr1099 with G proteins, thus altering its signaling efficiency. Additionally, Sodium orthovanadate, as a phosphatase inhibitor, prevents the dephosphorylation of proteins within the GPCR pathway, indirectly supporting Olfr1099 activity.
The influence of toxins like Cholera toxin, which activates the Gs alpha subunit, results in continuous cAMP production, indirectly augmenting Olfr1099 signaling through the GPCR cascade. Pertussis toxin's inactivation of Gi alpha subunits can also modify GPCR dynamics, potentially enhancing Olfr1099 activity. Okadaic acid, a serine/threonine phosphatase inhibitor, upholds phosphorylation states in GPCR pathways, further enhancing Olfr1099 signaling. Caffeine, through cAMP elevation, and Lithium carbonate, by inhibiting GSK-3, both indirectly contribute to the strengthening of Olfr1099's GPCR pathways. The direct activation of Olfr1099 by compounds like Isothiocyanates through GPCR-mediated signal transduction exemplifies the direct interaction of chemical activators with the receptor. Collectively, these activators employ diverse mechanisms to boost Olfr1099 function, primarily by enhancing GPCR-mediated signaling processes without the need for direct transcriptional or translational modulation of Olfr1099.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
This compound inhibits phosphodiesterases, preventing cAMP breakdown. This results in heightened cAMP levels, thereby indirectly enhancing Olfr1099 activity through strengthened GPCR signaling. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can modulate GPCR activity. In the case of Olfr1099, zinc may alter its conformation or interaction with G proteins, thereby enhancing its signaling capacity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
As a phosphatase inhibitor, this compound can prevent the dephosphorylation of proteins involved in the GPCR pathway, indirectly enhancing Olfr1099 signaling. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
It inactivates Gi alpha subunits, potentially altering GPCR dynamics, which could indirectly enhance Olfr1099 signaling by affecting its associated pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As a serine/threonine phosphatase inhibitor, it can enhance phosphorylation states within GPCR pathways, potentially enhancing Olfr1099 signaling. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
As a phosphodiesterase inhibitor, caffeine elevates cAMP levels, which can indirectly enhance Olfr1099 function by potentiating the GPCR pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium affects GPCR signaling by inhibiting GSK-3, which can indirectly enhance Olfr1099 activity as part of the GPCR pathways. | ||||||